Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Sex differences in cardiovascular disease risk
Wed January 27th - Doctors often mistake the development of hypertension in women for symptoms of menopause, according to a new analysis. More
Hope for end to melanoma rates growth
Wed January 27th - The growth in melanoma incidence in young adults has “stabilised” this century, suggesting that public health messages may have had some success, according to a new UK study. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 04/08/2020 VICKY P ADAM wrote:
I would like to thank WORLD HERBS CLINIC for reve... on Medieval remedy for bacterial ...
On 29/07/2020 Amdre wrote:
When i read many blogs online about cure to HSV, a... on Medieval remedy for bacterial ...
On 14/07/2020 margret wrote:
I was diagnosed of ALS (amyotrophic lateral sclero... on Heart abnormalities revealed i...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...

Blood pressure-heart valve disorder link

Thursday October 19th, 2017

People diagnosed with hypertension early in life face an increased risk of developing mitral regurgitation, according to a new British study.

Mitral regurgitation is a condition in which the heart's ability to circulate blood is reduced due to a backflow of blood into the heart. It leads to shortness of breath, tiredness, dizziness, chest pain and difficulty with even mild exercise. If untreated it carries a risk of heart failure.

Researchers led by Professor Kazem Rahimi of The George Institute for Global Health, Oxford, UK, analysed figures on 5.5 million adults in the UK for a follow-up period of ten years. This suggested that individuals diagnosed with hypertension in early life were at a significantly raised risk of later mitral regurgitation.

Details appeared in PLoS Medicine.

Professor Rahimi says: "Our research suggests this common and disabling valve disorder is not an inevitable consequence of ageing, as previously assumed, but may be preventable.

"Given the large and growing burden of mitral valve disease, particularly among older people, we believe these findings are likely to have significant implications for medical policy and practice around the world.

"With worldwide ageing and population growth, we are likely to see an increasing number of cases of this condition. We need to find effective and affordable measures to tackle it, and our study suggests one possible avenue for prevention, by reducing high blood pressure."

The research team explain that mitral regurgitation has previously been considered a degenerative disorder, as it occurs more often with age, to the focus has been on treatment with valve replacement surgery rather than on prevention.

They now believe that further research could show that lowering blood pressure through exercise, diet or medication could reduce the risk of the disorder developing.

Rahimi, K. et al. PLoS Medicine 17 October 2017 [abstract]

Tags: Europe | Heart Health | Pharmaceuticals | Transplant

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)